Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siponimod in Intracerebral Hemorrhage
NCT03338998Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2017
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of siponimod in intracerebral hemorrhage (ICH), sponsored by Novartis. Started Dec 2017; status: completed.
02
Drugs
siponimod
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03338998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338998.